AI Verdict
MOH has stronger fundamentals based on our AI analysis.
MOLN vs MOH Fundamental Comparison
| Metric | MOLN | MOH |
|---|---|---|
| Revenue | N/A | $45.4B |
| Net Income | N/A | $472.0M |
| Net Margin | N/A | 1.0% |
| ROE | N/A | 11.6% |
| ROA | N/A | 3.0% |
| Current Ratio | N/A | 1.69x |
| Debt/Equity | N/A | 0.93x |
| EPS | N/A | $8.92 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MOLN vs MOH: Frequently Asked Questions
Is MOLN or MOH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MOH has stronger fundamentals. MOLN is rated HOLD (15% confidence) while MOH is rated HOLD (65% confidence). This is not investment advice.
How does MOLN compare to MOH fundamentally?
MOLECULAR PARTNERS AG has ROE of N/A vs MOLINA HEALTHCARE, INC.'s 11.6%. Net margins are N/A vs 1.0% respectively.
Which stock pays higher dividends, MOLN or MOH?
MOLN has a dividend yield of N/A or no dividend while MOH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MOLN or MOH for long term?
For long-term investing, consider that MOLN has HOLD rating with 15% confidence, while MOH has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MOLN vs MOH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MOLN vs MOH, the AI consensus favors MOH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.